Supporting innovative, research-driven startups on the University of Iowa Campus
Funds expected to propel two lead radiopharmaceutical programs, VMT01 and VMT-𝛼-NET into Phase 1 imaging studies beginning in 2021 and accelerate development of radioisotope production technologies
AI for medical diagnoses, breath-through treatments for cystic fibrosis, surgical robotics, revolutionary engineering modeling, solar driven desalination-- our portfolio companies are taking the world by storm
Artificial Intelligence system for diagnosing disease through the eye
Genetic therapy for treating genetic lung disease including cystic fibrosis.
Research and development of mid and long wave infrared LEDs and lasers
Sunlight driven water treatment technologies
Robotic-assistive insertion systems for cochlear implants
Communication platform for nonverbal patients
Benchtop instrument to rapidly separate cancer cells from a biopsy
Multi-frequency oscillatory ventilator for patient-specific approach to respiratory therapy
Non-invasive, wearable device to manage blood sugar and enhance insulin sensitivity.